GLAND PHARMA LTDLong
Gland Pharma
Breakout possible in Gland Pharma.
Promoter Holding decreased from 57.86% to 51.83%.
FII holding increased from 3.59% to 6.88%.
DII holding increased from 25.23% to 32.83%
Promoter Holding decreased from 57.86% to 51.83%.
FII holding increased from 3.59% to 6.88%.
DII holding increased from 25.23% to 32.83%
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.